Blocking Mitochondrial Zn2+ Accumulation after Ischemia Reduces Mitochondrial Dysfunction and Neuronal Injury

Yuliya V Medvedeva1, Hong Z Yin1, Afsheen Bazrafkan1

  • 1Departments of Neurology.

Insights

Mitochondrial zinc accumulation contributes to brain injury after ischemia. Blocking zinc entry into mitochondria with ruthenium red attenuated neuronal death and dysfunction in animal models.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Ischemic brain injury is a major cause of death and disability.
  • Delayed neuronal death in vulnerable brain regions after transient ischemia requires mechanistic understanding for neuroprotection.
  • Mitochondria are implicated as key sites of zinc's injurious effects in the brain.

Purpose of the Study:

  • To investigate the role of zinc (Zn2+) accumulation in mitochondria during and after ischemic conditions.
  • To determine if targeting mitochondrial zinc entry can offer neuroprotection against ischemic brain injury.
  • To elucidate the contribution of mitochondrial zinc to delayed neuronal dysfunction and death post-ischemia.

Main Methods:

  • Oxygen-glucose deprivation (OGD) in murine hippocampal slices (both sexes).
  • Assessment of mitochondrial function (depolarization, swelling, fragmentation) and synaptic activity.
  • Pharmacological inhibition of mitochondrial zinc entry using ruthenium red (RR) or zinc chelation.
  • In vivo rat model (male) of transient global ischemia induced by asphyxial cardiac arrest.

Main Results:

  • Zn2+ accumulated in mitochondria during OGD, preceding and contributing to acute neuronal death.
  • Sublethal OGD led to progressive mitochondrial depolarization, increased synaptic activity, and mitochondrial structural changes (swelling, fragmentation).
  • Ruthenium red or zinc chelation post-OGD attenuated mitochondrial dysfunction and synaptic changes, with RR reversing swelling.
  • In vivo, RR infusion post-ischemia reduced CA1 neuronal injury associated with mitochondrial Zn2+ accumulation.

Conclusions:

  • Mitochondrial Zn2+ accumulation is a significant contributor to neuronal damage and dysfunction following ischemic events.
  • Targeting mitochondrial zinc entry, for example with ruthenium red, shows promise as a neuroprotective strategy after transient global ischemia.
  • Interventions aimed at reducing mitochondrial zinc post-ischemia could offer a therapeutic approach for treating ischemic brain injury.